Elixinol Wellness Limited ELLXF

Company Overview

Elixinol Wellness Limited (OTC: ELLXF, ASX: EXL) is an Australia-based wellness and hemp-derived products company focused on nutraceuticals, dietary supplements, and plant-based health products. The company has historically operated in the cannabidiol (CBD) and hemp wellness sector through branded consumer products marketed for sleep, stress, recovery, and general wellness applications. Elixinol Wellness has also maintained interests in hemp food and natural health categories through subsidiaries and related operating businesses. Its operations primarily target health-conscious consumers, specialty retailers, e-commerce channels, and wellness distributors.

The company evolved from a broader hemp and cannabis wellness platform into a more streamlined health and wellness business following restructuring activities and divestments. Elixinol Wellness previously expanded internationally through acquisitions and brand development initiatives tied to hemp-derived CBD products, particularly in the United States and Australia. Over time, the company adjusted its strategy in response to changing global CBD regulations, competitive pressures, and capital allocation priorities, placing greater emphasis on branded wellness products and operational efficiency.

Business Operations

Elixinol Wellness has historically generated revenue through the sale of branded hemp-derived wellness products, including tinctures, capsules, topical products, gummies, and hemp-based nutritional offerings. The company has operated through business units including Elixinol, its consumer wellness brand, and previously through hemp food and distribution-related operations. Revenue has primarily come from direct-to-consumer e-commerce channels, wholesale partnerships, and retail distribution arrangements across health and wellness markets.

The company’s operational footprint has included activities in Australia, the United States, and selected international markets. Elixinol Wellness has controlled product formulation, branding, digital sales infrastructure, and wellness-focused intellectual property associated with its products. Public filings and investor materials have referenced partnerships with distributors, retailers, and manufacturing providers supporting product development and fulfillment. Some historical operating structures and subsidiaries have changed following restructuring efforts and asset sales, and certain historical arrangements are no longer material based on recent public disclosures.

Strategic Position & Investments

Elixinol Wellness has pursued a strategy centered on consumer wellness, hemp-derived health products, and brand-led distribution. Strategic initiatives have included product portfolio optimization, cost reduction programs, and repositioning toward scalable wellness categories with clearer regulatory pathways. The company has also focused on preserving liquidity and improving operational discipline following volatility in the global CBD market.

Historically, Elixinol Wellness completed acquisitions and investments to broaden its exposure to hemp foods, natural health, and CBD wellness markets. Notable historical assets and operating interests have included Elixinol Global, Hemp Foods Australia, and related wellness subsidiaries. The company has also explored opportunities tied to emerging plant-based wellness trends and functional health products. Some earlier growth initiatives in international CBD expansion were subsequently moderated as regulatory conditions and market demand evolved. Certain investment outcomes and long-term strategic positioning remain subject to changing market conditions and public company disclosures.

Geographic Footprint

Elixinol Wellness is headquartered in Australia and has historically maintained operational exposure across North America, Australia, and selected international wellness markets. The company’s consumer brands and distribution activities have targeted customers in the United States, which has represented a major market for hemp-derived wellness products, as well as customers in the broader Asia-Pacific region.

The company’s geographic strategy has generally combined digital commerce with retail and wholesale distribution relationships. Public disclosures have indicated efforts to maintain international brand recognition while adapting operations to differing regulatory environments across jurisdictions. The scale of operations in some overseas markets has fluctuated over time due to restructuring initiatives and changes in market conditions.

Leadership & Governance

Elixinol Wellness was co-founded by entrepreneur and hemp industry advocate Paul Benhaim, who played a significant role in the company’s early expansion into hemp wellness and CBD consumer products. Leadership has emphasized brand development, regulatory compliance, disciplined capital management, and long-term participation in the global wellness sector.

Key executives and directors identified in recent public filings and company disclosures have included:

• Paul Benhaim – Co-Founder and Non-Executive Director
• Oliver Horn – Chief Executive Officer
• Ron Dufficy – Non-Executive Chairman
• Catherine Allerton – Non-Executive Director
• Nicholas Brinkhuis – Chief Financial Officer

The company’s governance approach has reflected the requirements of a publicly traded Australian company, with oversight through a board of directors and executive leadership team. Strategic commentary in public filings has consistently emphasized operational simplification, sustainable growth, and positioning the company within evolving global wellness and nutraceutical markets.